159722-87-9

Upstream product

• 5413-85-4 5-amino-4,6-dichloropyridimine 
• 159722-86-8 <(2S,3R)-2-(benzyloxy)non-8-en-3-yl>amine 
• 159722-84-6 <(2S,3S)-2-(benzyloxy)non-8-en-3-yl>-p-toluenesulfonate 
• 159722-85-7 (2S,3R)-3-azido-2-(benzyloxy)non-8-ene 
• 159722-83-5 (2S,3S)-2-(benzyloxy)non-8-en-3-ol 
• 93367-11-4 (2S,3S)-3-benzyloxy-1,2-epoxybutane 
• 34164-50-6 4-penten-1-ylmagnesium bromide 

Downstream Products

• 194783-29-4 (2S,3R)-3-(6-aminopurin-9-yl)-2-(benzyloxy)nonane-8,9-diol 
• 194783-28-3 (2S,3R)-2-(benzyloxy)-3-(6-chloropurin-9-yl)nonane-8,9-diol 
• 194783-27-2 (2S,3R)-2-(benzyloxy)-3-(6-aminopurin-9-yl)-8,9-epoxynonane 
• 159722-89-1 (2S,3R)-3-(6-aminopurin-9-yl)-2-(benzyloxy)nonan-9-ol 
• 176523-66-3 (2S,3R)-3-(6-aminopurin-9-yl)-2-(benzyloxy)non-8-ene 
• 159722-88-0 (2S,3R)-3-(6-chloropurin-9-yl)-2-(benzyloxy)non-8-ene 

Relevant academic research and scientific papers

Adenosine Deaminase Inhibitors. Synthesis and Biological Evaluation of Putative Metabolites of (+)-erythro-9-(2S-Hydroxy-3R-nonyl)adenine

The synthesis and biological evaluation of three chain-hydroxylated (+)-erythro-9-(2S-hydroxy-3R-nonyl)adenine derivatives are reported.Hydroxy groups at positions 9',8', and 8',9'(12,25, and 16) were introduced by either epoxidation or hydrobo